Nootai Biotech: Nootai Biotech: Convertible Debt-to-Stock Exchange Results and Stock Change Announcement
Nootech: 2024 Semi-Annual Equity Distribution Implementation Notice
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement regarding the profit distribution plan for the first half of 2024.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement of the results of the first vesting period of the 2023 Restricted Stock Incentive Plan and the listing of shares.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement on the Cancellation of Restricted Stock Incentive Plan for 2023.
Jiangsu Sinopep-Allsino Biopharmaceutical: The supervisory board's verification opinion on the first attribution list of the 2023 restricted stock incentive plan.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement regarding the first vesting period of the 2023 restricted stock incentive plan that meets the vesting conditions
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement on Adjusting Relevant Matters of Restricted Stock Incentive Plan in 2023
Guohao Law Firm (Hangzhou) legal opinion on the achievement of the first vesting condition, adjustment of grant price, and cancellation of certain restricted stocks related to Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd.'s restricted stock incentive plan for 2023.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement of Annual Equity Distribution Implementation in 2023
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement on the listing and circulation of part of the initial public offering of restricted shares
Nootech: Announcement on 2023 Profit Distribution Plan
Nuotai Biotech: Announcement of results of shareholders' share reduction
Nuotai Biotech: Announcement of results of shareholders\' share reduction
Notai Biotech: Reminder Notice Concerning Changes in Shareholders\' Equity of 5% or More Reached 1%
Nortel Biotech: Announcement on the results of centralized bidding by former senior managers to reduce their stock holdings
Nortel Biotech: Shareholders\' Share Reduction Plan Announcement
Notel Biotech: Early termination of shareholders\' share reduction plan and announcement of holdings reduction results
Legal Opinion of Guohao Law Firm (Hangzhou) on the granting of the 2023 Restricted Stock Incentive Plan of Jiangsu Nuotai Aosano Biopharmaceutical Co., Ltd.
Notel Biotech: Supervisory Board\'s inspection opinion on the list of incentive recipients granted by the company\'s 2023 restricted stock incentive plan (grant date)